new glp 1 agonist novo nordisk Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say Novo's GLP-1/Amylin Dual Agonist Amycretin
Description
In Eli Lillys head-to-head trials, Mounjaro demonstrated superiority to semaglutide in measures of fat mass reduction and time to achieving A1C and weight reduction targets
October 24, 2023
Version 1
Masood B, Moorthy M
Dietary modifications should focus on evidence-based patterns recommended by NICE and Diabetes UK
We have convenient locations to serve you in Apple Valley, CA and Victorville, CA
